(-)-demecolcine increases expression ISO RGD:1345576 6480464 Demecolcine results in increased expression of DUSP5 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1345576 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DUSP5 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1622924 6480464 epigallocatechin gallate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of DUSP5 protein] CTD PMID:34740634 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of DUSP5 protein CTD PMID:17337753 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of DUSP5 mRNA CTD PMID:21983209 17alpha-ethynylestradiol increases expression ISO RGD:1345576 6480464 Ethinyl Estradiol results in increased expression of DUSP5 mRNA CTD PMID:18936297 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of DUSP5 mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol affects expression ISO RGD:1345576 6480464 Ethinyl Estradiol affects the expression of DUSP5 mRNA CTD PMID:20170705 , PMID:26865667 17beta-estradiol affects expression ISO RGD:1345576 6480464 Estradiol affects the expression of DUSP5 mRNA CTD PMID:25321415 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of DUSP5 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1345576 6480464 Estradiol results in increased expression of DUSP5 mRNA CTD PMID:19153601 more ... 17beta-estradiol multiple interactions ISO RGD:1345576 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP5 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of DUSP5 mRNA CTD PMID:19619570 , PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1345576 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP5 mRNA more ... CTD PMID:19578757 , PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DUSP5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1345576 6480464 Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA CTD PMID:12377990 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1622924 6480464 Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA CTD PMID:19933214 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DUSP5 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of DUSP5 mRNA CTD PMID:17109745 2-hydroxypropanoic acid affects expression ISO RGD:1345576 6480464 Lactic Acid affects the expression of DUSP5 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1622924 6480464 tetrabromobisphenol A results in increased expression of DUSP5 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1622924 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DUSP5 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DUSP5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1345576 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DUSP5 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression ISO RGD:1622924 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DUSP5 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression ISO RGD:1345576 6480464 Decitabine affects the expression of DUSP5 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO RGD:1345576 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP5 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DUSP5 mRNA CTD PMID:24780913 acetylsalicylic acid affects expression EXP 6480464 Aspirin affects the expression of DUSP5 mRNA CTD PMID:12800193 acrylamide increases expression ISO RGD:1345576 6480464 Acrylamide results in increased expression of DUSP5 mRNA CTD PMID:32763439 afimoxifene multiple interactions ISO RGD:1345576 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of DUSP5 mRNA] CTD PMID:19153601 afimoxifene increases expression ISO RGD:1345576 6480464 afimoxifene results in increased expression of DUSP5 mRNA CTD PMID:19153601 aflatoxin B1 affects expression ISO RGD:1345576 6480464 Aflatoxin B1 affects the expression of DUSP5 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1345576 6480464 Aflatoxin B1 results in increased expression of DUSP5 mRNA CTD PMID:21632981 more ... aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA] CTD PMID:17109745 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of DUSP5 mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of DUSP5 mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression ISO RGD:1345576 6480464 Tretinoin results in increased expression of DUSP5 mRNA CTD PMID:23724009 , PMID:33167477 alpha-naphthoflavone multiple interactions ISO RGD:1345576 6480464 alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA], alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 protein] CTD PMID:19578757 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DUSP5 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1345576 6480464 Antirheumatic Agents results in decreased expression of DUSP5 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1345576 6480464 aristolochic acid I results in increased expression of DUSP5 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:1622924 6480464 arsenite results in decreased expression of DUSP5 mRNA CTD PMID:33053406 arsenous acid decreases expression ISO RGD:1345576 6480464 Arsenic Trioxide results in decreased expression of DUSP5 mRNA CTD PMID:20016248 astragaloside IV multiple interactions ISO RGD:1345576 243048424 astragaloside IV inhibits the reaction [beta-Glycerophosphate increases expression of DUSP5 mRNA and protein in Vascular smooth muscle cells] RGD astragaloside IV decreases expression ISO RGD:1622924 243048424 astragaloside IV decreases expression Dusp5 mRNA and protein in thoracic aorta RGD azathioprine increases expression ISO RGD:1345576 6480464 Azathioprine results in increased expression of DUSP5 mRNA CTD PMID:22623647 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene CTD PMID:33854195 benzo[a]pyrene decreases expression ISO RGD:1622924 6480464 Benzo(a)pyrene results in decreased expression of DUSP5 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1345576 6480464 Benzo(a)pyrene affects the methylation of DUSP5 intron, Benzo(a)pyrene affects the methylation of DUSP5 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1345576 6480464 Benzo(a)pyrene results in increased expression of DUSP5 mRNA CTD PMID:21632981 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345576 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1345576 6480464 benzo(e)pyrene results in increased methylation of DUSP5 promoter CTD PMID:30157460 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA] CTD PMID:17109745 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of DUSP5 mRNA CTD PMID:17109745 bexarotene decreases expression ISO RGD:1345576 6480464 bexarotene results in decreased expression of DUSP5 mRNA CTD PMID:17178900 bilirubin IXalpha increases expression ISO RGD:1345576 6480464 Bilirubin results in increased expression of DUSP5 mRNA CTD PMID:20196124 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1345576 6480464 Diethylhexyl Phthalate results in increased expression of DUSP5 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1345576 6480464 bisphenol A affects the expression of DUSP5 mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:1622924 6480464 bisphenol A results in increased expression of DUSP5 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:1345576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DUSP5 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DUSP5 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of DUSP5 mRNA CTD PMID:26496021 bortezomib multiple interactions ISO RGD:1345576 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of DUSP5 mRNA CTD PMID:25522274 butan-1-ol multiple interactions ISO RGD:1345576 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DUSP5 mRNA CTD PMID:29432896 cadmium atom increases expression ISO RGD:1345576 6480464 Cadmium results in increased expression of DUSP5 mRNA CTD PMID:24284285 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of DUSP5 mRNA CTD PMID:19010381 , PMID:21297351 cadmium dichloride increases expression ISO RGD:1345576 6480464 Cadmium Chloride results in increased expression of DUSP5 mRNA CTD PMID:25596134 calcitriol multiple interactions ISO RGD:1345576 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of DUSP5 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1345576 6480464 Calcitriol results in increased expression of DUSP5 mRNA CTD PMID:16002434 , PMID:21592394 cannabidiol increases expression ISO RGD:1345576 6480464 Cannabidiol results in increased expression of DUSP5 mRNA CTD PMID:33244087 carbon nanotube increases expression ISO RGD:1345576 6480464 Nanotubes, Carbon results in increased expression of DUSP5 mRNA CTD PMID:29348435 CGP 52608 multiple interactions ISO RGD:1345576 6480464 CGP 52608 promotes the reaction [RORA protein binds to DUSP5 gene] CTD PMID:28238834 chloroacetaldehyde increases expression ISO RGD:1345576 6480464 chloroacetaldehyde results in increased expression of DUSP5 mRNA CTD PMID:25596134 chloropicrin increases expression ISO RGD:1345576 6480464 chloropicrin results in increased expression of DUSP5 mRNA CTD PMID:26352163 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene CTD PMID:33854195 chlorpyrifos increases expression ISO RGD:1622924 6480464 Chlorpyrifos results in increased expression of DUSP5 mRNA CTD PMID:37019170 chromium(6+) increases expression ISO RGD:1345576 6480464 chromium hexavalent ion results in increased expression of DUSP5 mRNA CTD PMID:27793765 cidofovir anhydrous increases expression ISO RGD:1345576 6480464 Cidofovir results in increased expression of DUSP5 mRNA CTD PMID:25596134 cisplatin affects expression ISO RGD:1345576 6480464 Cisplatin affects the expression of DUSP5 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:1345576 6480464 Cisplatin results in increased expression of DUSP5 mRNA CTD PMID:25596134 more ... cobalt dichloride increases expression ISO RGD:1345576 6480464 cobaltous chloride results in increased expression of DUSP5 mRNA CTD PMID:19320972 , PMID:22941251 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of DUSP5 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of CPG21 mRNA CTD PMID:20187946 cocaine increases expression EXP 6480464 Cocaine results in increased expression of DUSP5 mRNA CTD PMID:27899881 copper atom multiple interactions ISO RGD:1345576 6480464 [Chelating Agents binds to Copper] which results in increased expression of DUSP5 mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO RGD:1345576 6480464 [Chelating Agents binds to Copper] which results in increased expression of DUSP5 mRNA more ... CTD PMID:20971185 more ... copper(II) sulfate increases expression ISO RGD:1345576 6480464 Copper Sulfate results in increased expression of DUSP5 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1345576 6480464 Asbestos, Crocidolite results in increased expression of DUSP5 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1345576 6480464 Asbestos, Crocidolite affects the expression of DUSP5 mRNA CTD PMID:25757056 curcumin increases expression ISO RGD:1345576 6480464 Curcumin results in increased expression of DUSP5 mRNA CTD PMID:17198877 cyclosporin A increases expression ISO RGD:1345576 6480464 Cyclosporine results in increased expression of DUSP5 mRNA CTD PMID:20106945 more ... cylindrospermopsin increases expression ISO RGD:1345576 6480464 cylindrospermopsin results in increased expression of DUSP5 mRNA CTD PMID:24921660 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of DUSP5 mRNA CTD PMID:22664269 dexamethasone multiple interactions ISO RGD:1345576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DUSP5 mRNA CTD PMID:28628672 diallyl trisulfide increases expression ISO RGD:1345576 6480464 diallyl trisulfide results in increased expression of DUSP5 mRNA CTD PMID:34995734 diarsenic trioxide decreases expression ISO RGD:1345576 6480464 Arsenic Trioxide results in decreased expression of DUSP5 mRNA CTD PMID:20016248 dibutyl phthalate increases expression ISO RGD:1622924 6480464 Dibutyl Phthalate results in increased expression of DUSP5 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of DUSP5 mRNA CTD PMID:21266533 dimethylarsinous acid increases expression ISO RGD:1345576 6480464 dimethylarsinous acid results in increased expression of DUSP5 mRNA CTD PMID:23487506 dinophysistoxin 1 increases expression ISO RGD:1345576 6480464 dinophysistoxin 1 results in increased expression of DUSP5 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO RGD:1345576 6480464 [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA more ... CTD PMID:19578757 dioxygen multiple interactions ISO RGD:1622924 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of DUSP5 protein, epigallocatechin gallate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of DUSP5 protein] CTD PMID:34740634 dioxygen increases expression ISO RGD:1345576 6480464 Oxygen deficiency results in increased expression of DUSP5 mRNA CTD PMID:25596134 disulfiram multiple interactions ISO RGD:1345576 6480464 [Disulfiram binds to Copper] which results in decreased expression of DUSP5 mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of DUSP5 mRNA CTD PMID:25152437 diuron decreases expression EXP 6480464 Diuron results in decreased expression of DUSP5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of DUSP5 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1345576 6480464 entinostat results in increased expression of DUSP5 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 febuxostat increases expression ISO RGD:1345576 6480464 Febuxostat results in increased expression of DUSP5 mRNA CTD PMID:35866629 fenarimol increases expression EXP 6480464 fenarimol results in increased expression of DUSP5 mRNA CTD PMID:28970091 fenofibrate increases expression ISO RGD:1345576 6480464 Fenofibrate results in increased expression of DUSP5 mRNA CTD PMID:25596134 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CPG21 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:1622924 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA] CTD PMID:28329830 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of CPG21 mRNA CTD PMID:17033635 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of DUSP5 mRNA CTD PMID:22664269 , PMID:28263823 genistein decreases expression ISO RGD:1345576 6480464 Genistein results in decreased expression of DUSP5 mRNA CTD PMID:20884965 genistein affects expression ISO RGD:1345576 6480464 Genistein affects the expression of DUSP5 mRNA CTD PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DUSP5 mRNA CTD PMID:33387578 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene CTD PMID:33854195 glyphosate affects expression ISO RGD:1345576 6480464 glyphosate affects the expression of DUSP5 mRNA CTD PMID:31295307 hydrogen peroxide increases expression ISO RGD:1345576 6480464 Hydrogen Peroxide results in increased expression of DUSP5 CTD PMID:18687144 hydrogen peroxide multiple interactions ISO RGD:1622924 6480464 DUSP5 protein inhibits the reaction [Hydrogen Peroxide results in decreased expression of SQSTM1 protein] more ... CTD PMID:34740634 hydrogen peroxide decreases expression ISO RGD:1622924 6480464 Hydrogen Peroxide results in decreased expression of DUSP5 mRNA, Hydrogen Peroxide results in decreased expression of DUSP5 protein CTD PMID:34740634 hydroquinone increases expression ISO RGD:1345576 6480464 hydroquinone results in increased expression of DUSP5 mRNA CTD PMID:31256213 ibuprofen increases expression ISO RGD:1345576 6480464 Ibuprofen results in increased expression of DUSP5 mRNA CTD PMID:25596134 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene CTD PMID:33854195 indometacin multiple interactions ISO RGD:1345576 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DUSP5 mRNA CTD PMID:28628672 isoprenaline decreases expression EXP 156430318 isoprenaline decreases expression of Dusp5 mRNA and protein in cardiac muscle cells RGD leflunomide increases expression ISO RGD:1345576 6480464 leflunomide results in increased expression of DUSP5 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1345576 6480464 licochalcone B results in increased expression of DUSP5 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:1345576 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DUSP5 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1345576 6480464 Lipopolysaccharides results in increased expression of DUSP5 mRNA CTD PMID:35811015 malathion increases expression ISO RGD:1345576 6480464 Malathion results in increased expression of DUSP5 mRNA CTD PMID:37047231 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of DUSP5 mRNA CTD PMID:28801915 manganese(II) chloride increases methylation EXP 6480464 manganese chloride results in increased methylation of DUSP5 gene CTD PMID:28801915 mercury dibromide increases expression ISO RGD:1345576 6480464 mercuric bromide results in increased expression of DUSP5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of DUSP5 mRNA CTD PMID:16507785 metformin increases expression EXP 6480464 Metformin results in increased expression of DUSP5 mRNA CTD PMID:25596134 metformin increases expression ISO RGD:1345576 6480464 Metformin results in increased expression of DUSP5 mRNA CTD PMID:25596134 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of DUSP5 mRNA CTD PMID:19564919 methapyrilene increases methylation ISO RGD:1345576 6480464 Methapyrilene results in increased methylation of DUSP5 promoter CTD PMID:30157460 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of DUSP5 gene CTD PMID:35440735 methylisothiazolinone increases expression ISO RGD:1345576 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of DUSP5 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1345576 6480464 methylmercuric chloride results in increased expression of DUSP5 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of DUSP5 mRNA CTD PMID:16809437 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1345576 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of DUSP5 mRNA CTD PMID:36695872 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of DUSP5 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO RGD:1345576 6480464 1-Methyl-4-phenylpyridinium results in increased expression of DUSP5 mRNA CTD PMID:24810058 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of DUSP5 mRNA CTD PMID:17412507 N-nitrosodiethylamine increases expression ISO RGD:1345576 6480464 Diethylnitrosamine results in increased expression of DUSP5 mRNA CTD PMID:21527772 N-nitrosodiethylamine increases expression ISO RGD:1622924 6480464 Diethylnitrosamine results in increased expression of DUSP5 mRNA CTD PMID:24535843 N-Nitrosopyrrolidine increases expression ISO RGD:1345576 6480464 N-Nitrosopyrrolidine results in increased expression of DUSP5 mRNA CTD PMID:32234424 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of DUSP5 protein CTD PMID:17337753 nickel atom increases expression ISO RGD:1345576 6480464 Nickel results in increased expression of DUSP5 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:1345576 6480464 nickel sulfate results in increased expression of DUSP5 mRNA CTD PMID:16780908 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of DUSP5 mRNA CTD PMID:20303128 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DUSP5 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of DUSP5 mRNA CTD PMID:16716893 p-chloromercuribenzoic acid increases expression ISO RGD:1345576 6480464 p-Chloromercuribenzoic Acid results in increased expression of DUSP5 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1345576 6480464 panobinostat results in increased expression of DUSP5 mRNA CTD PMID:26272509 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DUSP5 mRNA CTD PMID:17202762 , PMID:33387578 paracetamol increases expression ISO RGD:1345576 6480464 Acetaminophen results in increased expression of DUSP5 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1622924 6480464 Acetaminophen results in increased expression of DUSP5 mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:1622924 6480464 PANX1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of DUSP5 mRNA] CTD PMID:29246445 paraquat increases expression EXP 6480464 Paraquat results in increased expression of DUSP5 mRNA CTD PMID:32680482 perfluorononanoic acid increases expression ISO RGD:1345576 6480464 perfluoro-n-nonanoic acid results in increased expression of DUSP5 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of DUSP5 mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of DUSP5 gene CTD PMID:33148267 phenobarbital affects expression ISO RGD:1345576 6480464 Phenobarbital affects the expression of DUSP5 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1345576 6480464 Phenylmercuric Acetate results in increased expression of DUSP5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1345576 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DUSP5 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:1622924 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DUSP5 mRNA CTD PMID:19710929 potassium chromate increases expression ISO RGD:1345576 6480464 potassium chromate(VI) results in increased expression of DUSP5 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1345576 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DUSP5 mRNA CTD PMID:22079256 progesterone increases expression ISO RGD:1345576 6480464 Progesterone results in increased expression of DUSP5 mRNA CTD PMID:18037150 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of DUSP5 mRNA CTD PMID:28970091 quercetin increases expression ISO RGD:1345576 6480464 Quercetin results in increased expression of DUSP5 mRNA CTD PMID:21632981 rac-lactic acid affects expression ISO RGD:1345576 6480464 Lactic Acid affects the expression of DUSP5 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1345576 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of DUSP5 mRNA CTD PMID:19059307 resorcinol increases expression ISO RGD:1345576 6480464 resorcinol results in increased expression of DUSP5 mRNA CTD PMID:22623647 rotenone increases expression ISO RGD:1622924 6480464 Rotenone results in increased expression of DUSP5 mRNA CTD PMID:32937126 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1345576 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DUSP5 mRNA CTD PMID:35811015 SB 203580 multiple interactions ISO RGD:1622924 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA] CTD PMID:28329830 SB 431542 multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scopolamine decreases expression EXP 6480464 Scopolamine results in decreased expression of DUSP5 mRNA CTD PMID:17540011 silicon dioxide increases expression ISO RGD:1345576 6480464 Silicon Dioxide analog results in increased expression of DUSP5 mRNA, Silicon Dioxide results in increased expression of DUSP5 mRNA CTD PMID:22300531 more ... silicon dioxide increases expression ISO RGD:1622924 6480464 Silicon Dioxide results in increased expression of DUSP5 mRNA CTD PMID:23221170 silver atom increases expression ISO RGD:1345576 6480464 Silver results in increased expression of DUSP5 mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression ISO RGD:1345576 6480464 Silver results in increased expression of DUSP5 mRNA CTD PMID:26014281 , PMID:28959546 sodium arsenite increases expression ISO RGD:1345576 6480464 sodium arsenite results in increased expression of DUSP5 mRNA CTD PMID:29301061 Soman increases expression EXP 6480464 Soman results in increased expression of DUSP5 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:1345576 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUSP5 mRNA CTD PMID:36139627 sulforaphane increases expression ISO RGD:1345576 6480464 sulforaphane results in increased expression of DUSP5 mRNA CTD PMID:26833863 sunitinib decreases expression ISO RGD:1345576 6480464 Sunitinib results in decreased expression of DUSP5 mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:1345576 6480464 Tamoxifen results in increased expression of DUSP5 mRNA CTD PMID:15604281 tamoxifen multiple interactions ISO RGD:1345576 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of DUSP5 mRNA CTD PMID:19059307 Tanshinone I increases expression ISO RGD:1345576 6480464 tanshinone results in increased expression of DUSP5 mRNA CTD PMID:15849732 temozolomide decreases expression ISO RGD:1345576 6480464 Temozolomide results in decreased expression of DUSP5 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1345576 6480464 tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1345576 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of DUSP5 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1345576 6480464 Testosterone results in increased expression of DUSP5 mRNA CTD PMID:21592394 thapsigargin decreases expression ISO RGD:1345576 6480464 Thapsigargin results in decreased expression of DUSP5 mRNA CTD PMID:29453283 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene CTD PMID:33854195 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DUSP5 mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DUSP5 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:1345576 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUSP5 mRNA CTD PMID:36139627 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of DUSP5 mRNA CTD PMID:22664269 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of DUSP5 mRNA CTD PMID:17553608 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of DUSP5 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1345576 6480464 trichostatin A results in increased expression of DUSP5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:1345576 6480464 trichostatin A affects the expression of DUSP5 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1345576 6480464 Triclosan results in decreased expression of DUSP5 mRNA CTD PMID:30510588 triphenyl phosphate increases expression ISO RGD:1345576 6480464 triphenyl phosphate results in increased expression of DUSP5 mRNA CTD PMID:35776891 triptonide increases expression ISO RGD:1622924 6480464 triptonide results in increased expression of DUSP5 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1345576 6480464 tris(2-butoxyethyl) phosphate affects the expression of DUSP5 mRNA CTD PMID:29024780 trovafloxacin increases expression ISO RGD:1622924 6480464 trovafloxacin results in increased expression of DUSP5 mRNA CTD PMID:35537566 tunicamycin decreases expression ISO RGD:1345576 6480464 Tunicamycin results in decreased expression of DUSP5 mRNA CTD PMID:29453283 urethane increases expression ISO RGD:1345576 6480464 Urethane results in increased expression of DUSP5 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of DUSP5 mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1345576 6480464 Valproic Acid results in increased methylation of DUSP5 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1345576 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1345576 6480464 Valproic Acid results in increased expression of DUSP5 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1345576 6480464 Valproic Acid affects the expression of DUSP5 mRNA CTD PMID:25979313 valsartan multiple interactions ISO RGD:1345576 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of DUSP5 mRNA] CTD PMID:19225232 vanadyl sulfate increases expression ISO RGD:1345576 6480464 vanadyl sulfate results in increased expression of DUSP5 mRNA CTD PMID:16330358 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of DUSP5 mRNA CTD PMID:17074742 zinc atom increases expression ISO RGD:1345576 6480464 Zinc deficiency results in increased expression of DUSP5 mRNA CTD PMID:22171008 zinc atom multiple interactions ISO RGD:1345576 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of DUSP5 mRNA CTD PMID:18593933 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of DUSP5 mRNA CTD PMID:17074742 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of DUSP5 mRNA CTD PMID:17074742 zinc(0) multiple interactions ISO RGD:1345576 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of DUSP5 mRNA CTD PMID:18593933 zinc(0) increases expression ISO RGD:1345576 6480464 Zinc deficiency results in increased expression of DUSP5 mRNA CTD PMID:22171008 zoledronic acid decreases expression ISO RGD:1345576 6480464 zoledronic acid results in decreased expression of DUSP5 mRNA CTD PMID:24714768 , PMID:25596134